» Authors » Nicolas Dubuisson

Nicolas Dubuisson

Explore the profile of Nicolas Dubuisson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 219
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Abou-Samra M, Dubuisson N, Marino A, Selvais C, Romain V, Davis-Lopez de Carrizosa M, et al.
Antioxidants (Basel) . 2025 Jan; 13(12. PMID: 39765879
Adiponectin (ApN) is a hormone with potent effects on various tissues. We previously demonstrated its ability to counteract Duchenne muscular dystrophy (DMD), a severe muscle disorder. However, its therapeutic use...
2.
Selvais C, Davis-Lopez de Carrizosa M, Versele R, Dubuisson N, Noel L, Brichard S, et al.
Antioxidants (Basel) . 2024 Sep; 13(9). PMID: 39334732
Sarcopenia, characterized by loss of muscle mass, quality, and function, poses significant risks in aging. We previously demonstrated that long-term treatment with AdipoRon (AR), an adiponectin receptor agonist, alleviated myosteatosis...
3.
Smeets N, Gheldof A, Dequeker B, Poleur M, Slootjes S, Van Parijs V, et al.
Pediatr Neurol . 2024 Jul; 158:57-65. PMID: 38964204
Background: Congenital myasthenic syndromes (CMS) are a group of genetic disorders characterized by impaired neuromuscular transmission. CMS typically present at a young age with fatigable muscle weakness, often with an...
4.
De Wel B, Iterbeke L, Huysmans L, Peeters R, Goosens V, Dubuisson N, et al.
Eur J Neurol . 2024 Mar; 31(7):e16282. PMID: 38504654
Background And Purpose: Because Becker muscular dystrophy (BMD) is a heterogeneous disease and only few studies have evaluated adult patients, it is currently still unclear which outcome measures should be...
5.
Dubuisson N, Claeys K, Schoser B
Front Neurol . 2024 Feb; 15:1370538. PMID: 38375464
No abstract available.
6.
Dubuisson N, Versele R, Davis-Lopez de Carrizosa M, Selvais C, Noel L, Planchon C, et al.
Cells . 2023 Aug; 12(16). PMID: 37626911
Duchenne muscular dystrophy (DMD) is one of the most devastating myopathies, where severe inflammation exacerbates disease progression. Previously, we demonstrated that adiponectin (ApN), a hormone with powerful pleiotropic effects, can...
7.
Dubuisson N, Davis-Lopez de Carrizosa M, Versele R, Selvais C, Noel L, Van den Bergh P, et al.
Front Immunol . 2022 Dec; 13:1049076. PMID: 36569900
Background: Duchenne muscular dystrophy (DMD) is the most common inherited human myopathy. Typically, the secondary process involving severe inflammation and necrosis exacerbate disease progression. Previously, we reported that the NLRP3...
8.
Dubuisson N, Versele R, Planchon C, Selvais C, Noel L, Abou-Samra M, et al.
Int J Mol Sci . 2022 Dec; 23(24). PMID: 36555721
Duchenne muscular dystrophy (DMD) is a progressive disease caused by the loss of function of the protein dystrophin. This protein contributes to the stabilisation of striated cells during contraction, as...
9.
Selvais C, Davis-Lopez de Carrizosa M, Nachit M, Versele R, Dubuisson N, Noel L, et al.
J Cachexia Sarcopenia Muscle . 2022 Dec; 14(1):464-478. PMID: 36513619
Background: Obesity among older adults has increased tremendously. Obesity accelerates ageing and predisposes to age-related conditions and diseases, such as loss of endurance capacity, insulin resistance and features of the...
10.
Dubuisson N, Versele R, Davis-Lopez de Carrizosa M, Selvais C, Brichard S, Abou-Samra M
Cells . 2021 Nov; 10(11). PMID: 34831246
Over the last decade, innate immune system receptors and sensors called inflammasomes have been identified to play key pathological roles in the development and progression of numerous diseases. Among them,...